Grass MATA MPL
Sponsors
Allergy Therapeutics
Conditions
Seasonal Allergic RhinitisType I Hypersensitivity
Phase 1
Assessment of Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick Testing
CompletedNCT00104390
Start: 2005-03-31End: 2005-04-30Target: 14Updated: 2010-06-10
A Study of Tolerability and Safety of a New Cumulative Dose of Grass MATA MPL
CompletedNCT03931993
Start: 2017-01-16End: 2017-04-27Updated: 2019-04-30
Phase 2
Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen
CompletedNCT00104377
Start: 2005-03-31End: 2005-11-30Target: 70Updated: 2010-06-17
Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy Vaccine
CompletedNCT00133146
Start: 2005-09-12End: 2005-11-23Updated: 2021-07-13